Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Eosinophilia with aberrant T cells and elevated serum levels of interleukin-2 and interleukin-15

Article Abstract:

The case of a 34-year-old man with eosinophilia is described. Eosinophilia is caused by excess levels of a white blood cell called eosinophils. The excess eosinophil levels can damage organs. Researchers also found excess levels of natural killer cells, as well as interleukin-15 and interleukin-2. The patient's symptoms may have been triggered by an infectious organism, which triggered the production of interleukin-15 and interleukin-2, which in turn triggered the activation of natural killer cells. The activated killer cells then produced proteins that stimulate eosinophil production.

Author: Means-Markwell, Melissa, Burgess, Timothy, DeKeratry, Dominic, O'Neil, Kevin, Mascola, John, Fleisher, Thomas, Lucey, Daniel
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2000
Health aspects, Case studies, Eosinophilia, Killer cells

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Outcome analysis and cost assessment in immunologic disorders

Article Abstract:

Expensive biologic therapies for immune disorders may save treatment costs by reducing the rate of infections and hospitalizations. Chronic granulomatous disease causes lifelong risk of severe infections. Annual treatment with interferon gamma can cost about $20,000, but substantially reduces infections and can produce a net savings in medical costs. Intravenous immunoglobulin (IVIG) provides antibodies in patients with deficiency diseases. Despite substantial cost, IVIG may reduce bacterial pneumonia expenditures 81% in patients with agammaglobulinemia.

Author: Cunningham-Rundles, Charlotte, Stadtmauer, Gary
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
Care and treatment, Evaluation, Economic aspects, Interferon gamma, Cost benefit analysis, Immunologic diseases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: Transplantation immunology. Chronic graft-vs-host disease
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.